Literature DB >> 15664832

Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.

Min-Yong Li1, Keng-Chang Tsai, Lin Xia.   

Abstract

A chemical feature based pharmacophore model was developed for alpha(1A)-adrenoceptor antagonists by HypoGen module implemented in catalyst software package. The best scoring pharmacophore hypothesis, Hypo1, consisted of four important chemical features (one positive ion, one hydrogen-bond donor, one aromatic ring, and one hydrophobic group). The results of our study provide a valuable tool in designing new leads with desired biological activity by virtual screening.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664832     DOI: 10.1016/j.bmcl.2004.11.032

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Discovery of Quinazoline-Based Fluorescent Probes to α1-Adrenergic Receptors.

Authors:  Wei Zhang; Zhao Ma; Wenhua Li; Geng Li; Laizhong Chen; Zhenzhen Liu; Lupei Du; Minyong Li
Journal:  ACS Med Chem Lett       Date:  2015-03-30       Impact factor: 4.345

Review 2.  Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors.

Authors:  Jaromir Myslivecek
Journal:  Life (Basel)       Date:  2022-04-19

3.  A novel structural framework for α(1A/D)-adrenoceptor selective antagonists identified using subtype selective pharmacophores.

Authors:  Emily S Stoddart; Sevvandi Senadheera; Iain J A MacDougall; Renate Griffith; Angela M Finch
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

4.  Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents.

Authors:  Monika Marcinkowska; Magdalena Kotańska; Agnieszka Zagórska; Joanna Śniecikowska; Monika Kubacka; Agata Siwek; Adam Bucki; Maciej Pawłowski; Marek Bednarski; Jacek Sapa; Małgorzata Starek; Monika Dąbrowska; Marcin Kołaczkowski
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.